• Please log in or register to access this feature.
You have free access to this content

An update on the mechanisms of the psychostimulant effects of caffeine

  1. Sergi Ferré

Article first published online: 18 DEC 2007

DOI: 10.1111/j.1471-4159.2007.05196.x

Issue

Journal of Neurochemistry

Journal of Neurochemistry

Volume 105, Issue 4, pages 1067–1079, May 2008

Additional Information

How to Cite

Ferré, S. (2008), An update on the mechanisms of the psychostimulant effects of caffeine. Journal of Neurochemistry, 105: 1067–1079. doi: 10.1111/j.1471-4159.2007.05196.x

Author Information

  1. National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, USA

*Address correspondence and reprint requests to Sergi Ferré, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 5500 Nathan Shock Dr, Baltimore, MD 21224, USA. E-mail: sferre@intra.nida.nih.gov

Publication History

  1. Issue published online: 18 DEC 2007
  2. Article first published online: 18 DEC 2007
  3. Received October 8, 2007; revised manuscript received November 26, 2007; accepted December 10, 2007.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (291K)

References

  • Agnati L. F., Ferré S., Lluis C., Franco R. and Fuxe K. (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55, 509–550.
  • Antoniou K., Papadopoulou-Daifoti Z., Hyphantis T., Papathanasiou G., Bekris E., Marselos M., Panlilio L., Muller C. E., Goldberg S. R. and Ferré S. (2005) A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors. Psychopharmacology 183, 154–162.
  • Ballarin M., Reiriz J., Ambrosio S. and Mahy N. (1995) Effect of locally infused 2-chloroadenosine, an A1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Neurosci. Lett. 185, 29–32.
  • Basheer R., Strecker R. E., Thakkar M. M. and McCarley R. W. (2004) Adenosine and sleep-wake regulation. Prog. Neurobiol. 73, 379–396.
  • Bedingfield J. B., King D. A. and Holloway F. A. (1998) Cocaine and caffeine: conditioned place preference, locomotor activity, and additivity. Pharmacol. Biochem. Behav. 61, 291–296.
  • Bennett H. J. and Semba K. (1998) Immunohistochemical localization of caffeine-induced c-Fos protein expression in the rat brain. J. Comp. Neurol. 401, 89–108.
    Direct Link:
  • Borycz J., Pereira M. F., Melani A., Rodrigues R. J., Kofalvi A., Panlilio L., Pedata F., Goldberg S. R., Cunha R. A. and Ferré S. (2007) Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments. J. Neurochem. 101, 355–363.
    Direct Link:
  • Brockwell N. T. and Beninger R. J. (1996) The differential role of A1 and A2A adenosine receptor subtypes in locomotor activity and place conditioning in rats. Behav. Pharmacol. 7, 373–383.
  • Canals M., Marcellino D., Fanelli F. et al. (2003) Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J. Biol. Chem. 278, 46741–46749.
  • Carriba P., Ortiz O., Patkar K. et al. (2007) Striatal adenosine A(2A) and cannabinoid CB(1) receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 32, 2249–2259.
  • Cauli O. and Morelli M. (2005) Caffeine and the dopaminergic system. Behav. Pharmacol. 16, 63–77.
  • Cauli O., Pinna A., Valentini V. and Morelli M. (2003) Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. Neuropsychopharmacology 28, 1752–1759.
  • Ciruela F., Casado V., Rodrigues R. J. et al. (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci. 26, 2080–2087.
  • Conlay L. A., Conant J. A., DeBros F. and Wurtman R. (1997) Caffeine alters plasma adenosine levels. Nature 389, 136.
  • Corsi C., Melani A., Bianchi L. and Pedata F. (2000) Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. Neuroreport 11, 2591–2595.
  • De Luca M. A., Bassareo V., Bauer A. and Di Chiara G. (2007) Caffeine and accumbens shell dopamine. J. Neurochem. 103, 157–163.
  • Durcan M. J. and Morgan P. F. (1989) Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice. Eur. J. Pharmacol. 168, 285–290.
  • El Yacoubi M., Ledent C., Menard J. F., Parmentier M., Costentin J. and Vaugeois J. M. (2000) The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A (2A) receptors. Br. J. Pharmacol. 129, 1465–1473.
    Direct Link:
  • Elliott J. M. and Beveridge T. J. (2005) Psychostimulants and monoamine transporters: upsetting the balance. Curr. Opin. Pharmacol. 5, 94–100.
  • Fedorchak P. M., Mesita J., Plater S. A. and Brougham K. (2002) Caffeine-reinforced conditioned flavor preferences in rats. Behav. Neurosci. 116, 334–346.
  • Ferré S., Von Euler G., Johansson B., Fredholm B. B. and Fuxe K. (1991a) Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc. Natl Acad. Sci. USA 88, 7238–7241.
  • Ferré S., Herrera-Marschitz M., Grabowska-Anden M., Casas M., Ungerstedt U. and Anden N. E. (1991b) Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice. Eur. J. Pharmacol. 192, 31–37.
  • Ferré S., Fuxe K., Von Euler G., Johansson B. and Fredholm B. B. (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51, 501–512.
  • Ferré S., O’Connor W. T., Fuxe K. and Ungerstedt U. (1993) The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13, 5402–5406.
  • Ferré S., Popoli P., Gimenez-Llort L., Finnman U. B., Martinez E., Scotti de Carolis A. and Fuxe K. (1994) Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors. Neuroreport 6, 73–76.
  • Ferré S., O’Connor W. T., Svenningsson P. et al. (1996) Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur. J. Neurosci. 8, 1545–1553.
    Direct Link:
  • Ferré S., Fredholm B. B., Morelli M., Popoli P. and Fuxe K. (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20, 482–487.
  • Ferré S., Torvinen M., Antoniou K., Irenius E., Civelli O., Arenas E., Fredholm B. B. and Fuxe K. (1998) Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells. J. Biol. Chem. 273, 4718–4724.
  • Ferré S., Rimondini R., Popoli P., Reggio R., Pezzola A., Hansson A. C., Andersson A. and Fuxe K. (1999) Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour. Eur. J. Neurosci. 11, 3884–3892.
    Direct Link:
  • Ferré S., Popoli P., Gimenez-Llort L., Rimondini R., Muller C. E., Stromberg I., Ogren S. O. and Fuxe K. (2001) Adenosine/dopamine interaction: implications for the treatment of Parkinson’s disease. Parkinsonism Relat. Disord. 7, 235–241.
  • Ferré S., Karcz-Kubicha M., Hope B. T. et al. (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc. Natl Acad. Sci. USA 99, 11940–11945.
  • Ferré S., Borycz J., Goldberg S. R., Hope B. T., Morales M., Lluis C., Franco R., Ciruela F. and Cunha R. (2005) Role of adenosine in the control of homosynaptic plasticity in striatal excitatory synapses. J. Integr. Neurosci. 4, 445–464.
  • Ferré S., Diamond I., Goldberg S. R., Yao L., Hourani S. M., Huang Z. L., Urade Y. and Kitchen I. (2007a) Adenosine A (2A) receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog. Neurobiol. 83, 332–347.
  • Ferré S., Agnati L. F., Ciruela F., Lluis C., Woods A. S., Fuxe K. and Franco R. (2007b) Neurotransmitter receptor heteromers and their integrative role in ‘local modules’: the striatal spine module. Brain Res. Rev. 55, 55–67.
  • Ferré S., Ciruela F., Woods A. S., Lluis C. and Franco R. (2007c) Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci. 30, 440–446.
  • Fisone G., Borgkvist A. and Usiello A. (2004) Caffeine as a psychomotor stimulant: mechanism of action. Cell. Mol. Life Sci. 61, 857–872.
  • Frary C. D., Johnson R. K. and Wang M. Q. (2005) Food sources and intakes of caffeine in the diets of persons in the United States. J. Am. Diet. Assoc. 105, 110–113.
  • Fredholm B. B. (1980) Are methylxanthine effects due to antagonism of endogenous adenosine? Trends Pharmacol. Sci. 1, 129–132.
  • Fredholm B. B., Battig K., Holmen J., Nehlig A. and Zvartau E. E. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83–133.
  • Fredholm B. B., Ijzerman A. P., Jacobson K. A., Klotz K. N. and Linden J. (2001a) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527–552.
  • Fredholm B. B., Irenius E., Kull B. and Schulte G. (2001b) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol. 61, 443–448.
  • Fuxe K. and Ungerstedt U. (1974) Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists. Med. Biol. 52, 48–54.
  • Garrett B. E. and Griffiths R. R. (1997) The role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacol. Biochem. Behav. 57, 533–541.
  • George S. R., O’Dowd B. F. and Lee S. P. (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discov. 1, 808–820.
  • Gerfen C. R. (2004) Basal ganglia, in The Rat Nervous System (PaxinosG., ed.), pp. 445–508. Elsevier Academic Press, Amsterdam.
  • Ginés S., Hillion J., Torvinen M. et al. (2000) Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc. Natl Acad. Sci. USA 97, 8606–8611.
  • Golembiowska K. and Zylewska A. (1997) Adenosine receptors – the role in modulation of dopamine and glutamate release in the rat striatum. Pol. J. Pharmacol. 49, 317–322.
  • Griffiths R. R. and Woodson P. P. (1988) Reinforcing effects of caffeine in humans. J. Pharmacol. Exp. Ther. 246, 21–29.
  • Griffiths R. R., Juliano L. M. and Chausmer A. (2003) Caffeine: pharmacology and clinical effects, in Principles of Addiction Medicine (GrahamA. W., SchultzT. K., Mayo-SmthM. F., RiesR. K. and WilfordB. B., eds), Third Edition, pp. 193–224 American Society of Addiction Medicine, Chevy Chase, MD.
  • Gubitz A. K., Widdowson L., Kurokawa M., Kirkpatrick K. A. and Richardson P. J. (1996) Dual signalling by the adenosine A2a receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals. J. Neurochem. 67, 374–381.
    Direct Link:
  • Hakansson K., Galdi S., Hendrick J., Snyder G., Greengard P. and Fisone G. (2006) Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. J. Neurochem. 96, 482–488.
    Direct Link:
  • Halldner L., Lozza G., Lindstrom K. and Fredholm B. B. (2000) Lack of tolerance to motor stimulant effects of a selective adenosine A (2A) receptor antagonist. Eur. J. Pharmacol. 406, 345–354.
  • Halldner L., Aden U., Dahlberg V., Johansson B., Ledent C. and Fredholm B. B. (2004) The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors. Neuropharmacology 46, 1008–10017.
  • Hanson G. R., Sandoval V., Riddle E. and Fleckenstein A. E. (2004) Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications. Ann. NY Acad. Sci. 1025, 146–150.
    Direct Link:
  • Hernandez-Lopez S., Tkatch T., Perez-Garci E., Galárraga E., Bargas J., Hamm H. and Surmeier D. J. (2000) D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLCβ1-IP3-calcineurin-signaling cascade. J. Neurosci. 20, 8987–8995.
  • Hertz L. and Zielke R. (2004) Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 27, 735–743.
  • Hervé D., Le Moine C., Corvol J. C., Belluscio L., Ledent C., Fienberg A. A., Jaber M., Studler J. M. and Girault J. A. (2001) Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J. Neurosci. 21, 4390–4399.
  • Hillion J., Canals M., Torvinen M. et al. (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J. Biol. Chem. 277, 18091–18097.
  • Holtzman S. G., Mante S. and Minneman K. P. (1991) Role of adenosine receptors in caffeine tolerance. J. Pharmacol. Exp. Ther. 256, 62–68.
  • Huang Z. L., Urade Y. and Hayaishi O. (2007) Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr. Opin. Pharmacol. 7, 33–38.
  • Ikemoto S. (2007) Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 56, 27–78.
  • Jacobson K. A., Nikodijevic O., Padgett W. L., Gallo-Rodriguez C., Maillard M. and Daly J. (1993) W. 8- (3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo. FEBS Lett. 323, 141–144.
  • Jacobson K. A., Von Lubitz D. K., Daly J. W. and Fredholm B. B. (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol. Sci. 17, 108–113.
  • James J. E. and Rogers P. J. (2005) Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation. Psychopharmacology 182, 1–8.
  • Jarvis S. E. and Zamponi G. W. (2001) Interactions between presynaptic Ca2+ channels, cytoplasmic messengers and proteins of the synaptic vesicle release complex. Trends Pharmacol. Sci. 22, 519–525.
  • Jiang H., Jackson-Lewis V., Muthane U., Dollison A., Ferreira M., Espinosa A., Parsons B. and Przedborski S. (1993) Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats. Brain Res. 613, 347–351.
  • Juliano L. M. and Griffiths R. R. (2004) A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176, 1–29.
  • Karcz-Kubicha M., Antoniou K., Terasmaa A. et al. (2003) Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 28, 1281–1291.
  • Kull B., Ferré S., Arslan G., Svenningsson P., Fuxe K., Owman C. and Fredholm B. B. (1999) Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochem. Pharmacol. 58, 1035–1045.
  • Kuzmin A., Johansson B., Gimenez L., Ogren S. O. and Fredholm B. B. (2006) Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice. Eur. Neuropsychopharmacol. 16, 129–136.
  • Ledent C., Vaugeois J. M., Schiffmann S. N., Pedrazzini T., El Yacoubi M., Vanderhaeghen J. J., Costentin J., Heath J. K., Vassart G. and Parmentier M. (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388, 674–678.
  • Lee K. W., Hong J. H., Choi I. Y. et al. (2002) Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J. Neurosci. 22, 7931–7940.
  • Lee K. W., Kim Y., Kim A. M., Helmin K., Nairn A. C. and Greengard P. (2006) Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc. Natl Acad. Sci. USA 103, 3399–3404.
  • Leenders A. G. and Sheng Z. H. (2005) Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacol. Ther. 105, 69–84.
  • Lindskog M., Svenningsson P., Pozzi L., Kim Y., Fienberg A. A., Bibb J. A., Fredholm B. B., Nairn A. C., Greengard P. and Fisone G. (2002) Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418, 774–778.
  • Lupica C. R., Cass W. A., Zahniser N. R. and Dunwiddie T. V. (1990) Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J. Pharmacol. Exp. Ther. 252, 1134–1141.
  • Marshall F. H. (2001) Heterodimerization of G-protein-coupled receptors in the CNS. Curr. Opin. Pharmacol. 1, 40–44.
  • Muller C. E. and Ferré S. (2007) Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders. Recent Pat. CNS Drug Disc. 2, 1–21.
  • Mumford G. K. and Holtzman S. G. (1991) Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat. J. Pharmacol. Exp. Ther. 258, 857–865.
  • Munzar P., Justinova Z., Kutkat S. W., Ferré S. and Goldberg S. R. (2002) Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 161, 348–355.
  • Myers K. P. and Izbicki E. V. (2006) Reinforcing and aversive effects of caffeine measured by flavor preference conditioning in caffeine-naive and caffeine-acclimated rats. Physiol. Behav. 88, 585–596.
  • Nehlig A. (1999) Are we dependent upon coffee and caffeine? A review on human and animal data Neurosci. Biobehav. Rev. 23, 563–576.
  • Nehlig A. and Boyet S. (2000) Dose-response study of caffeine effects on cerebral functional activity with a specific focus on dependence. Brain Res. 858, 71–77.
  • Newman E. A. (2003) New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci. 26, 536–542.
  • Nishi A., Liu F., Matsuyama S., Hamada M., Higashi H., Nairn A. C. and Greengard P. (2003) Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc. Natl Acad. Sci. USA 100, 1322–1327.
  • Okada M., Mizuno K. and Kaneko S. (1996) Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 212, 53–56.
  • Okada M., Kiryu K., Kawata Y., Mizuno K., Wada K., Tasaki H. and Kaneko S. (1997) Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur. J. Pharmacol. 321, 181–188.
  • Okada M., Nutt D. J., Murakami T., Zhu G., Kamata A., Kawata Y. and Kaneko S. (2001) Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J. Neurosci. 21, 628–640.
  • Pascual O., Casper K. B., Kubera C., Zhang J., Revilla-Sanchez R., Sul J. Y., Takano H., Moss S. J., McCarthy K. and Haydon P. G. (2005) Astrocytic purinergic signaling coordinates synaptic networks. Science 310, 113–116.
  • Patkina N. A. and Zvartau E. E. (1998) Caffeine place conditioning in rats: comparison with cocaine and ethanol. Eur. Neuropsychopharmacol. 8, 287–291.
  • Pinna A., Fenu S. and Morelli M. (2001) Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats. Synapse 39, 233–238.
    Direct Link:
  • Popoli P., Betto P., Reggio R. and Ricciarello G. (1995) Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur. J. Pharmacol. 287, 215–217.
  • Popoli P., Gimenez-Llort L., Pezzola A., Reggio R., Martinez E., Fuxe K. and Ferré S. (1996) Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents. Neurosci. Lett. 218, 209–213.
  • Popoli P., Reggio R., Pezzola A., Fuxe K. and Ferré S. (1998) Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats. Neurosci. Lett. 251, 201–204.
  • Popoli P., Regio R. and Pezzola A. (2000) Effects of SCH 58261, an adenosine A (2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake. Neuropsychopharmacology 22, 522–529.
  • Porkka-Heiskanen T., Strecker R. E. and McCarley R. W. (2000) Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience 99, 507–517.
  • Preston Z., Lee K., Widdowson L., Freeman T. C., Dixon A. K. and Richardson P. J. (2000) Adenosine receptor expression and function in rat striatal cholinergic interneurons. Br. J. Pharmacol. 130, 886–890.
    Direct Link:
  • Prinster S. C., Hague C. and Hall R. A. (2005) Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57, 289–298.
  • Pycock C. J. (1980) Turning behavior in animals. Neuroscience 5, 461–514.
  • Quarta D., Ferré S., Solinas M., You Z. B., Hockmeyer J., Popoli P. and Goldberg S. R. (2004a) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J. Neurochem. 88, 1151–1158.
    Direct Link:
  • Quarta D., Borycz J., Solinas M. et al. (2004b) Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. J. Neurochem. 91, 873–880.
    Direct Link:
  • Rall T. W. (1982) Evolution of the mechanism of action of methylxanthines from calcium mobilizers to antagonists of adenosine receptors. Pharmacologist 24, 277–297.
  • Rashid A. J., So C. H., Kong M. M., Furtak T., El-Ghundi M., Cheng R., O’Dowd B. F. and George S. R. (2007) D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc. Natl Acad. Sci. USA 104, 654–659.
  • Rosin D. L., Hettinger B. D., Lee A. and Linden J. (2003) Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function. Neurology 61, S12–S18.
  • Schiffmann S. N., Fisone G., Moresco R., Cunha R. and Ferré S. (2007) Adenosine A2A receptors and basal ganglia physiology. Prog. Neurobiol. 83, 277–292.
  • Shindou T., Nonaka H., Richardson P. J., Mori A., Kase H. and Ichimura M. (2002) Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via cyclic AMP dependent mechanisms in the rat globus pallidus. Br. J. Pharmacol. 136, 296–302.
    Direct Link:
  • Snyder S. H. (1985) Adenosine as a neuromodulator. Annu. Rev. Neurosci. 8, 103–124.
  • Snyder S. H. and Ferris C. D. (2000) Novel neurotransmitters and their neuropsychiatric relevance. Am. J. Psychiatry 157, 1738–1751.
  • Snyder S. H., Katims J. J., Annau Z., Bruns R. F. and Daly J. W. (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc. Natl Acad. Sci. USA 78, 3260–3264.
  • Solinas M., Ferré S., You Z. B., Karcz-Kubicha M., Popoli P. and Goldberg S. R. (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J. Neurosci. 22, 6321–6324.
  • Solinas M., Ferré S., Antoniou K. et al. (2005) Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats. Psychopharmacology 179, 576–586.
  • Solinas M., Panlilio L. V., Justinova Z., Yasar S. and Goldberg S. R. (2006) Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats. Nat. Protoc. 1, 1194–1206.
  • Song I. and Huganir R. L. (2002) Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci. 25, 578–588.
  • Spealman R. D. (1988) Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism. Psychopharmacology 95, 19–24.
  • Spealman R. D. and Coffin V. L. (1986) Behavioral effects of adenosine analogs in squirrel monkeys: relation to adenosine A2 receptors. Psychopharmacology 90, 419–421.
  • Stromberg I., Popoli P., Muller C. E., Ferré S. and Fuxe K. (2000) Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum. Eur. J. Neurosci. 12, 4033–4037.
    Direct Link:
  • Sulzer D., Sonders M. S., Poulsen N. W. and Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406–433.
  • Surmeier D. J., Song W. J. and Yan Z. (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16, 6579–6591.
  • Svenningsson P., Nomikos G. G., Ongini E. and Fredholm B. B. (1977) Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79, 753–764.
  • Svenningsson P., Lindskog M., Ledent C., Parmentier M., Greengard P., Fredholm B. B. and Fisone G. (2000) Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc. Natl Acad. Sci. USA 97, 1856–1860.
  • Tinley E. M., Durlach P. J. and Yeomans M. R. (2004) How habitual caffeine consumption and dose influence flavour preference conditioning with caffeine. Physiol. Behav. 82, 317–324.
  • Torres G. E., Gainetdinov R. R. and Caron M. G. (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4, 13–25.
  • Ungerstedt U. (1971) Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367, 69–93.
  • Valjent E., Pagès C., Hervé D., Girault J. A. and Caboche J. (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur. J. Neurosci. 19, 1826–1836.
    Direct Link:
  • Wise R. A. (2004) Dopamine, learning and motivation. Nat. Neurosci. Rev. 5, 483–494.
  • Wood P. L., Kim H. S., Boyar W. C. and Hutchison A. (1989) Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation. Neuropharmacology 28, 21–25.
  • Zetterstrom T. and Fillenz M. (1990) Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur. J. Pharmacol. 180, 137–143.
View Full Article (HTML) Get PDF (291K)